Tata India Pharma & Healthcare Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1896 Cr | ₹1296 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.14 | 2.14 |
Manager | Dhruv Muchhal | Meeta Shetty |
ISIN Code | INF179KC1HL7 | INF277K016A9 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -1.48% | -0.68% |
6 Month | 10.24% | 7.41% |
1 Year | 6.87% | -0.08% |
3 Year | - | 22.82% |
5 Year | - | 18.06% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 1.96% | 1.91% |
1 Year | 12.01% | 8.63% |
3 Year | - | 21.01% |
5 Year | - | 18.6% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 27.59% | 9.76% |
3 Year | - | 18.6% |
5 Year | - | 15.32% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | - | 16.05% |
Sharp | - | 0.90% |
Beta | - | 0.98% |
Alpha | - | -0.49% |
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Dhruv Muchhal | Meeta Shetty |
Total AUM | ₹520687 Cr | ₹17847 Cr |
Funds Managed | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 7.7 | 4.14 |
Mid Cap | 30.89 | 37.44 |
Small Cap | 35.06 | 33.28 |
Large Cap | 26.35 | 25.14 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.03 | 1.72 |
Basic Materials | 2.31 | 2.64 |
Healthcare | 96.66 | 94.07 |
Financial Services | - | 1.58 |
Top Comparisons
Aditya Birla Sun Life Retirement Fund-The 30s Plan-Regular Growth
3Y Returns15.88%
Axis Retirement Fund - Dynamic Plan - Regular Growth
3Y Returns14.21%
Franklin India Opportunities Fund - Growth
3Y Returns30.21%
QUANT COMMODITIES FUND REGULAR PLAN GROWTH
3Y Returns0%
Sundaram Short Duration Fund Regular Growth
3Y Returns7.59%
Axis Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.82%
Kotak Large Cap Fund - Growth
3Y Returns16.37%
Motilal Oswal Large Cap Fund - Regular (G)
3Y Returns0%